MMF does not increase malignancy, death after transplant

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1525, 2006-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switch to MMF beneficial in liver transplant recipients?

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Sodium phosphate: Hyperphosphataemia, extensive calcinosis and death after enema administration in a renal transplant recipient: case report

Reactions Weekly, Vol. 1, Iss. 1111, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients: A Systematic Review

By Gutierrez-Dalmau Alex Campistol Josep M.

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1167-1198

Adis International

Access to resources Recommend Favorite

Immunosuppressants may increase cancer risk post-transplant

Reactions Weekly, Vol. 1, Iss. 1134, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Micronutrient supplements may increase peri- and neonatal death

Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite